ARTL
ARTL
NASDAQ · Pharmaceuticals

Artelo Biosciences Inc

$5.34
-0.45 (-7.77%)
As of Mar 25, 6:05 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +194.0% upside
Low Target $11.87
Average Target $15.70
High Target $22.80
Current Price $5.34
Current
$5.34
Target
$15.70
$11.87 $15.70 avg $22.80
Scenario Analysis
Bear Case
$11.87
122.3%
Low target
Base Case
$15.70
+194.0%
Avg target
Bull Case
$22.80
+327.0%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$85.80
-93.8% from high
52-Week Low
$3.15
+69.5% from low
Target vs 52W High
$15.70
-81.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%